公司概覽
業務類別 Biotechnology
業務概覽 Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
公司地址 350 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
電話號碼 +1 650 624-3000
傳真號碼 +1 650 624-3010
公司網頁 https://www.cytokinetics.com
員工數量 673
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Robert I. Blum Director, President and Chief Executive Officer 美元 853.07K 17/04/2026
Dr. Fady Ibraham Malik, M.D.,PhD Executive Vice President, Research and Development 美元 629.78K 17/04/2026
Mr. Jeffrey J. Hessekiel Executive Vice President, Chief Legal and Administrative Officer 美元 85.25K 17/04/2026
Mr. Sung H. Lee Executive Vice President, Chief Financial Officer and Principal Accounting Officer 美元 572.92K 17/04/2026
Mr. Andrew M. Callos Executive Vice President and Chief Commercial Officer 美元 581.68K 17/04/2026
 
董事會成員
董事會 職務 更新日期
Ms. B. Lynne Parshall, Esq.,J.D. Independent Director 17/04/2026
Dr. John T. Henderson, M.B. Chairman of the Board 17/04/2026
Ms. Nancy J. Wysenski Independent Director 17/04/2026
Mr. Robert I. Blum Director, President and Chief Executive Officer 17/04/2026
Dr. Wendell D. Wierenga,PhD Independent Director 17/04/2026
Dr. Edward M. Kaye, M.D. Independent Director 17/04/2026
Mr. James M. Daly Independent Director 17/04/2026
Mr. Robert E. Landry Independent Director 17/04/2026
Ms. Muna Bhanji, Ph. Independent Director 17/04/2026
Dr. Robert A. Harrington, M.D. Independent Director 17/04/2026
 
所屬ETF (更新日期: 14/11/2026 02:25)
代號 名稱 佔比% ▼ 持有日期
FADFirst Trust Multi Cap Gr AlphaDEX® ETF<0.000001%07/10/2026
FDIFFidelity Disruptors ETF<0.000001%02/03/2026
FELVFidelity Enhanced Large Cap Value ETF<0.000001%06/05/2026
FFLGFidelity Fundamental Large Cap Gr ETF<0.000001%05/10/2026
FFSMFidelity Fundamental Small-Mid Cap ETF<0.000001%31/07/2026
FFTYCapForce IBD® 50 ETF<0.000001%20/07/2026
FMEDFidelity Disruptive Medicine ETF<0.000001%02/06/2026
FNXFirst Trust Mid Cap Core AlphaDEX® ETF<0.000001%07/10/2026
FNYFirst Trust Mid Cap Growth AlphaDEX® ETF<0.000001%07/10/2026
FSSTFidelity Sustainable U.S. Equity ETF<0.000001%31/07/2025
FTLSFirst Trust Long/Short Equity ETF<0.000001%04/06/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF<0.000001%31/08/2026
GUSEGoldman Sachs Enhanced U.S. Equity ETF<0.000001%09/10/2026
ISMDInspire Small/Mid Cap ETF<0.000001%01/10/2026
JDOCJPMorgan Healthcare Leaders ETF<0.000001%15/04/2026
JHSCJHancock Multifactor Small Cap ETF<0.000001%17/09/2026
JSMLJanus Henderson Small Cap Gr Alpha ETF<0.000001%01/07/2026
MHIGMilliman Healthcare Inflation Guard ETF<0.000001%22/09/2026
MHIPMilliman Healthcare Inflation Plus ETF<0.000001%22/09/2026
OMFSInvesco Russell 2000® Dynamic Mltfct ETF<0.000001%08/04/2026
  1    2    3    4    5    6    7   8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.